Results 171 to 180 of about 7,695,341 (360)

Correction: Cell-free mitochondrial DNA as a potential predictor for hypoxic stress. [PDF]

Mol Biol Rep
Qu Q, Xiao C, Liu X, Huang A, Li H, Xu G, Shao N, Zhao Y, Gao B.   +8 more
europepmc   +1 more source

Marketization of the basic school

, 2011
Marketization of the basic school The report investigates the consequences of the increasing use of New Public Management initiatives in the basic schools in Copenhagen based on interviews from five schools.
Gren, Signe, Løber, Trine, Meyer, Kathrine, Aastrup, Amalie, Christiansen, Ellen   +4 more
core  

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

The relationship between shyness and short video addiction among college students: chain mediating role of social support and basic psychological needs. [PDF]

Front Psychol
Bu X, Li X, Li B, Zhang X.
europepmc   +1 more source

Dual-chirality flexagon linkages with infinite eversion and surface reconfigurability. [PDF]

Proc Natl Acad Sci U S A
Lin J, Miao Z, Zhang H, Dong K, Lu H, Feng H, Dai JS.   +6 more
europepmc   +1 more source

DNA Methylation and Its Basic Function

Neuropsychopharmacology, 2013
Lisa D. Moore, Thuc M. Le, G. Fan
semanticscholar   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Knowledge of HPV and HPV vaccine and its association with vaccination willingness among female undergraduates: A comparative cross-sectional study between healthcare and non-healthcare majors in Chengdu, China. [PDF]

PLoS One
Zhao M, Lei J, Feng Q, Lai S, Liang Q, Xie M.   +5 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Impacts of Remnant Cholesterol and Residual Inflammation on Clinical Outcomes After Ischemic Stroke. [PDF]

JACC Adv
Chen Y, Zhu Y, Du M, Peng Y, Xu T, Zhang Y, Li H, Zhong C.   +7 more
europepmc   +1 more source